Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

465
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
465
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

357
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
357
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

313
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
313
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

550
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
550
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

263
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
263
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

525
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
525

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.

The American journal of gastroenterology·2026
Same author

Patient Experience, Gender, Age, Race, and Social Determinants of Health.

Gastroenterology·2026
Same author

Gastric Emptying, Colon Filling, and Multiregional Gut Transit Delays Are Prevalent on Glucagon-Like Peptide-1 Agonists.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

How I Approach Flatulence.

The American journal of gastroenterology·2025
Same author

Potential impact of aortic stenosis diagnosis on mortality and other in-hospital complications in patients with pancreatic cancer undergoing pancreaticoduodenectomy.

Porto biomedical journal·2025
Same author

HIV-Negative African American Man with Gastrointestinal Kaposi Sarcoma Associated with Adalimumab Treatment for Cardiac Sarcoidosis: A Case Report.

The American journal of case reports·2025

Related Experiment Video

Updated: Sep 28, 2025

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.1K

Burden of Constipation: Looking Beyond Bowel Movements.

Lucinda A Harris1, Christopher H Chang2

  • 1Mayo Clinic Scottsdale, Scottsdale, Arizona, USA.

The American Journal of Gastroenterology
|March 31, 2022
PubMed
Summary

Patients with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) often feel more in control of their symptoms than healthcare providers perceive. This disconnect contributes to inadequate management and significant burdens.

More Related Videos

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

599
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.0K

Related Experiment Videos

Last Updated: Sep 28, 2025

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.1K
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

599
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.0K

Area of Science:

  • Gastroenterology
  • Patient-Reported Outcomes
  • Healthcare Disparities

Background:

  • Chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) impose substantial social and economic burdens.
  • Understanding the root causes of these conditions is crucial for effective management.
  • A significant gap exists in the perception of symptom severity and impact between patients and healthcare providers (HCPs).

Purpose of the Study:

  • To investigate the discrepancies in perception between patients and HCPs regarding CIC and IBS-C symptoms.
  • To explore patient engagement with healthcare services for constipation management.
  • To identify factors influencing treatment-seeking behavior and satisfaction.

Main Methods:

  • The study likely involved surveys or interviews with patients diagnosed with CIC or IBS-C and their HCPs.
  • Data analysis focused on comparing patient-reported experiences with HCP assessments of symptom impact and management.
  • Exploration of demographic factors, including sex and cultural differences, in healthcare consultation patterns.

Main Results:

  • Patients reported higher levels of symptom acceptance and control compared to HCP perceptions.
  • Only one-third of individuals with CIC or IBS-C formally consulted an HCP.
  • Fewer than half used medications, primarily over-the-counter options, with only one-fifth of those seeking help feeling well-managed.

Conclusions:

  • A notable disconnect between patient and HCP perceptions contributes to the underdiagnosis and inadequate management of CIC and IBS-C.
  • Many individuals with CIC and IBS-C experience suboptimal symptom control, leading to significant personal and societal costs.
  • Addressing these perceptual gaps and improving access to effective treatments are essential to alleviate the burden of these conditions.